Endogenous Technology Adoption and Medical Costs

Abstract

Despite the claim that technology has been one of the most important drivers of healthcare spending growth over the past decades, technology variables are rarely introduced explicitly in cost equations. Furthermore, technology is often considered exogenous. Using 1996-2007 panel data on Swiss geographical areas, we assessed the impact of technology availability on per capita healthcare spending covered by basic health insurance whilst controlling for the endogeneity of health technology availability variables. Our results suggest that medical research, patent intensity and the density of employees working in the medical device industry are influential factors for the adoption of technology and can be used as instruments for technology availability variables in the cost equation. These results are similar to previous findings: CT and PET scanner adoption is associated with increased healthcare spending, whilst increased availability of percutaneous transluminal coronary angioplasty facilities is associated with reductions in per capita spending. However, our results suggest that the magnitude of these relationships is much greater in absolute value than that suggested by previous studies that did not control for the possible endogeneity of the availability of technologies. Copyright © 2016 John Wiley & Sons, Ltd.

Assessing Pelvic Tilt in Patients Undergoing Total Hip Arthroplasty Using Sensor Technology

“…Further research is needed to demonstrate cost-effectiveness or neutrality in consideration of overall clinical outcomes with the use of wearable technology, although the theoretical benefits of less imaging requirements and in-person visits, for instance, suggest the potential for cost reduction while maintaining or improving patient outcomes [ 29 ]. The development of this technology from the industry standpoint and adoption of this technology from the provider standpoint, however, is not without significant cost [ 39 ]. Nevertheless, the idea that a short- and intermediate-term cost increase lending to a long-term decrease in utilization and outcomes-related costs driven by improvements in patient satisfaction and outcomes is a decision that must be weighed by healthcare providers and hospital systems [ 39 , 40 ].…”

“…The development of this technology from the industry standpoint and adoption of this technology from the provider standpoint, however, is not without significant cost [ 39 ]. Nevertheless, the idea that a short- and intermediate-term cost increase lending to a long-term decrease in utilization and outcomes-related costs driven by improvements in patient satisfaction and outcomes is a decision that must be weighed by healthcare providers and hospital systems [ 39 , 40 ].…”

Patterns of adoption of robotic radical prostatectomy in the United States and England

“…Rapid advances in medical innovation over the past decades have led to an increase in the range of alternatives for the diagnosis and treatment of disease. [1][2][3][4] While these technological advances have been shown to be beneficial to care and improve outcomes, they are not always cost-effective. 1,2,5 Indeed, some of the growth in health care spending across high-income countries is attributed to medical innovation.…”

Technology assessment and cost-effectiveness in orthopedics: how to measure outcomes and deliver value in a constantly changing healthcare environment

“…The development of new medical technology is one of the primary driving forces of the enormous increase in healthcare costs [3]. While the long-term gains in clinical outcomes may eventually reduce the overall financial outlay [4], initial capital investment in new technology increases cost in the shortand mid-term [3].…”

“…While the long-term gains in clinical outcomes may eventually reduce the overall financial outlay [4], initial capital investment in new technology increases cost in the shortand mid-term [3]. Some technological advances ultimately result in improved patient outcomes, but surgeons must weigh the benefits of new technology against the increased costs resulting from its adoption, especially in a limited resource environment such as the US healthcare system.…”